- Home
- CVAC vs CCD Comparison
CVAC vs CCD Comparison
Compare CVAC & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CCD
- Stock Information
- Founded
- CVAC 2000
- CCD 2014
- Country
- CVAC Germany
- CCD United States
- Employees
- CVAC N/A
- CCD N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CCD Trusts Except Educational Religious and Charitable
- Sector
- CVAC Health Care
- CCD Finance
- Exchange
- CVAC Nasdaq
- CCD Nasdaq
- Market Cap
- CVAC 818.8M
- CCD 656.6M
- IPO Year
- CVAC 2020
- CCD N/A
- Fundamental
- Price
- CVAC $3.12
- CCD $20.37
- Analyst Decision
- CVAC Buy
- CCD
- Analyst Count
- CVAC 2
- CCD 0
- Target Price
- CVAC $10.00
- CCD N/A
- AVG Volume (30 Days)
- CVAC 717.4K
- CCD 96.1K
- Earning Date
- CVAC 04-10-2025
- CCD 01-01-0001
- Dividend Yield
- CVAC N/A
- CCD 10.61%
- EPS Growth
- CVAC N/A
- CCD N/A
- EPS
- CVAC 0.75
- CCD N/A
- Revenue
- CVAC $554,073,921.00
- CCD N/A
- Revenue This Year
- CVAC N/A
- CCD N/A
- Revenue Next Year
- CVAC $66.34
- CCD N/A
- P/E Ratio
- CVAC $4.19
- CCD N/A
- Revenue Growth
- CVAC 895.54
- CCD N/A
- 52 Week Low
- CVAC $2.22
- CCD $16.93
- 52 Week High
- CVAC $5.28
- CCD $24.68
- Technical
- Relative Strength Index (RSI)
- CVAC 53.48
- CCD 41.31
- Support Level
- CVAC $3.05
- CCD $20.10
- Resistance Level
- CVAC $3.02
- CCD $20.78
- Average True Range (ATR)
- CVAC 0.19
- CCD 0.71
- MACD
- CVAC 0.06
- CCD 0.07
- Stochastic Oscillator
- CVAC 79.14
- CCD 64.66
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.